Tag: SHP2 Inhibition
Cooley advises Jacobio’s USD2bn licensing deal with AstraZeneca
Cooley has advised Jacobio Pharmaceuticals on a record-breaking USD 2.02 billion global licensing agreement with AstraZeneca
Cooley has advised Jacobio Pharmaceuticals on a record-breaking USD 2.02 billion global licensing agreement with AstraZeneca
Follow us on LinkedIn